Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.2K
Overview
51.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

960
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
960
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

2.0K
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision therapeutic tRNA rescue of nonsense mutation R166X in <i>KCNJ13</i> to restore K<sup>+</sup> channel function.

Journal of precision medicine (Amsterdam, Netherlands)·2026
Same author

Identification and enrichment of human retinal organoid-derived red/green cone-competent precursors with enhanced axon dynamics.

Stem cell research & therapy·2026
Same author

Emerging interest of anti-integrin αvβ6 antibodies for the diagnosis and prognosis of IBD and primary sclerosing cholangitis at the gut-liver interface.

Inflammatory bowel diseases·2026
Same author

Systems serology identifies FcR-related autoantibody signatures and functions for Sjögren's syndrome.

EMBO molecular medicine·2026
Same author

CTCF regulates wild-type and recombinant AAV gene expression by shaping viral chromatin.

bioRxiv : the preprint server for biology·2026
Same author

Engineered tRNA reduces vision loss in a mouse model of Leber congenital amaurosis.

Signal transduction and targeted therapy·2026

Related Experiment Video

Updated: Jan 16, 2026

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.2K

A user's guide to designing efficient and safe mucosal vaccines: Challenges & potentials.

Divya Sinha1, Prajwal Kargal Gopalakrishna1, Stephane Paul1,2,3

  • 1CIRI-Centre International de Recherche en Infectiologie, Team GIMAP, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR5308, CIC 1408 Vaccinology, F42023, Saint-Etienne, France.

Oxford Open Immunology
|October 6, 2025
PubMed
Summary

Mucosal immunization offers a promising strategy for pathogen protection at mucosal entry points. This review details challenges and strategies for effective mucosal vaccine development, aiming for robust local and systemic immunity.

Keywords:
adjuvantsmucosal immunitymucosal vaccinesvaccine delivery

More Related Videos

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion&#45;Encapsulated Retinoic Acid System for Mucosal Vaccination
06:02

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

1.2K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.0K

Related Experiment Videos

Last Updated: Jan 16, 2026

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.2K
Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion&#45;Encapsulated Retinoic Acid System for Mucosal Vaccination
06:02

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

1.2K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.0K

Area of Science:

  • Immunology
  • Vaccinology
  • Microbiology

Background:

  • Mucosal surfaces are primary entry points for many pathogens.
  • The mucosal immune system presents unique challenges for vaccine development due to its tolerogenic nature and physical barriers.

Purpose of the Study:

  • To provide a practical overview of the mucosal immune system.
  • To explore the benefits and challenges of mucosal vaccination.
  • To discuss strategies and recent advances in mucosal vaccine development.

Main Methods:

  • Review of existing literature on mucosal immunology and vaccinology.
  • Analysis of challenges such as mechanical barriers and immune tolerance.
  • Discussion of strategies to enhance antigen uptake and immunogenicity.
  • Exploration of novel mucosal delivery routes and combinations.

Main Results:

  • Mucosal vaccination can induce both local and systemic immune responses.
  • Key challenges include mechanical barriers, immune tolerance, and environmental variability.
  • Strategies to overcome tolerance and improve antigen uptake are crucial for vaccine efficacy.

Conclusions:

  • Mucosal immunization is a viable strategy for protection against mucosal pathogens.
  • Overcoming challenges in mucosal tolerance and delivery is key to successful vaccine development.
  • Further research into novel routes and delivery systems will advance mucosal vaccinology.